SHS Capital
Millionen Euro für künstliche Gelenke
FAZ 08/07/2023
German healthcare investor SHS Capital acquires majority stake in Dutch firm CAM Bioceramics
tech.eu 07/07/2023
German PE investor SHS Capital closes €270 million sixth fund to bet hard on European healthcare
EU Startups 13/09/2023
Mental Health Startups: Diese fünf Investoren müsst ihr kennen!
Gründerszene 01/12/2023
» The collaboration with getpress was very effective right from the start. After we defined goals and KPIs together, the team worked like an extended arm of SHS and was able to achieve good results after just a few weeks. In addition to the professional briefings for the interviews, I was particularly impressed by the strong network behind getpress, which often led to media placements that we had defined as targets in advance. «
Dr. Cornelius Maas, Partner at SHS Capital
SHS Capital is the only German private equity fund that specializes exclusively in healthcare investments. For over 30 years, the fund has been investing in high-growth companies in the fields of medical technology, life science, digital health and diagnostics, with the aim of developing them into European market leaders.
Most recently, SHS secured 270 million euros, and in addition to many well-known family offices, attracted important investors such as the European Investment Fund, the L-Bank, as well as Helsana Health Invest.
Compared to VCs, SHS Capital invests in companies at a somewhat later stage as a growth investor. The investments are mostly medium-size companies and scale-ups/growth companies with high growth rates of 30-50% per year, with a relatively low risk compared to VCs.
Sofia Katsikis
PR Manager & Jr. Teamlead
Thank you for your request.
We will get back to you asap.